ROCKVILLE, Md. (AP) _ Regenxbio Inc. (RGNX) on Tuesday reported a loss of $19.6 million in its fourth quarter.
On a per-share basis, the Rockville, Maryland-based company said it had a loss of 74 cents.
The biotechnology company posted revenue of $1.7 million in the period.
For the year, the company reported that its loss widened to $63 million, or $2.38 per share. Revenue was reported as $4.6 million.
Regenxbio shares have climbed 12 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $20.85, a climb of 60 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGNX at https://www.zacks.com/ap/RGNX
Keywords: Regenxbio, Earnings Report